Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

The management of elderly diabetic saudi patients with acute coronary syndrome.

Kinsara AJ, Hasanin AM.

Heart Views. 2013 Jan;14(1):1-4. doi: 10.4103/1995-705X.107112.

2.

Managing acute coronary syndrome: evidence-based approaches.

Spinler SA.

Am J Health Syst Pharm. 2007 Jun 1;64(11 Suppl 7):S14-24.

PMID:
17519441
4.

Impact of diabetes on hospital adverse cardiovascular outcomes in acute coronary syndrome patients: Data from the Saudi project of acute coronary events.

Alnemer KA, Alfaleh HF, Alhabib KF, Ullah A, Hersi A, Alsaif S, Taraben A, Hussein G, Butt M.

J Saudi Heart Assoc. 2012 Oct;24(4):225-31. doi: 10.1016/j.jsha.2012.08.002. Epub 2012 Aug 27.

5.

Use of glycoprotein IIb/IIIa inhibitors in invasively-treated patients with non-ST elevation acute coronary syndrome.

De Servi S, Mariani M, Vandoni P, Dellavalle A, Politi A, Poletti F, Bonizzoni E, Leoncinie M; Registro Osservazionale Angina Instabile (ROSAI-2) Investigators..

J Cardiovasc Med (Hagerstown). 2006 Mar;7(3):159-65.

PMID:
16645379
6.

Baseline characteristics, management practices, and in-hospital outcomes of patients with acute coronary syndromes: Results of the Saudi project for assessment of coronary events (SPACE) registry.

Alhabib KF, Hersi A, Alfaleh H, Alnemer K, Alsaif S, Taraben A, Kashour T, Bakheet A, Qarni AA, Soomro T, Malik A, Ahmed WH, Abuosa AM, Butt MA, Almurayeh MA, Zaidi AA, Hussein GA, Balghith MA, Abu-Ghazala T.

J Saudi Heart Assoc. 2011 Oct;23(4):233-9. doi: 10.1016/j.jsha.2011.05.004. Epub 2011 Jun 1.

8.
9.

[The clinical use of the GPIIb/IIIa inhibitors eptifibatide and tirofiban in the treatment of acute coronary syndromes of the "non-ST elevation" type].

Galli M, Maggioni AP, Vassanelli C, Tavazzi L.

Ital Heart J Suppl. 2000 Feb;1(2):202-11. Review. Italian.

PMID:
10731377
10.

Acute coronary syndrome in young adults: the Thai ACS Registry.

Tungsubutra W, Tresukosol D, Buddhari W, Boonsom W, Sanguanwang S, Srichaiveth B; Thai ACS Registry..

J Med Assoc Thai. 2007 Oct;90 Suppl 1:81-90.

PMID:
18431890
11.

Low-molecular-weight heparin compared with unfractionated heparin for patients with non-ST-segment elevation acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE initiative.

Singh KP, Roe MT, Peterson ED, Chen AY, Mahaffey KW, Goodman SG, Harrington RA, Smith SC Jr, Gibler WB, Ohman EM, Pollack CV Jr; CRUSADE Investigators..

J Thromb Thrombolysis. 2006 Jun;21(3):211-20.

PMID:
16683212
12.

Diabetic patients with acute coronary syndromes in the UK: high risk and under treated. Results from the prospective registry of acute ischaemic syndromes in the UK (PRAIS-UK).

Bakhai A, Collinson J, Flather MD, de Arenaza DP, Shibata MC, Wang D, Adgey JA; KAA Fox for the PRAIS-UK Investigators..

Int J Cardiol. 2005 Apr 8;100(1):79-84.

PMID:
15820289
13.

Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland.

Poloński L, Gasior M, Gierlotka M, Kalarus Z, Cieśliński A, Dubiel JS, Gil RJ, Ruzyłło W, Trusz-Gluza M, Zembala M, Opolski G.

Kardiol Pol. 2007 Aug;65(8):861-72; discussion 873-4.

15.
16.
17.

Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy.

Pride YB, Mohanavelu S, Zorkun C, Kunadian V, Giugliano RP, Newby LK, Braunwald E, Califf RM, Harrington RA, Gibson CM; EARLY ACS Investigators..

JACC Cardiovasc Interv. 2012 Sep;5(9):927-35. doi: 10.1016/j.jcin.2012.05.007.

18.

Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trials.

Tricoci P, Newby LK, Hasselblad V, Kong DF, Giugliano RP, White HD, Théroux P, Stone GW, Moliterno DJ, Van de Werf F, Armstrong PW, Prabhakaran D, Rasoul S, Bolognese L, Durand E, Braunwald E, Califf RM, Harrington RA.

Circ Cardiovasc Qual Outcomes. 2011 Jul;4(4):448-58. doi: 10.1161/CIRCOUTCOMES.110.960294. Epub 2011 Jun 28. Review.

19.

Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes.

Dabbous OH, Anderson FA Jr, Gore JM, Eagle KA, Fox KA, Mehta RH, Goldberg RJ, Agnelli G, Steg PG; GRACE Investigators..

Heart. 2008 Feb;94(2):159-65. Epub 2007 Jun 17.

PMID:
17575335
20.

Antiplatelet intervention in acute coronary syndrome.

Arora RR, Rai F.

Am J Ther. 2009 Sep-Oct;16(5):e29-40. doi: 10.1097/MJT.0b013e31804c7238. Review.

PMID:
19092648

Supplemental Content

Support Center